INNOVATIVE SOLTNS & SUPP ($ISSC) is expected to release its quarterly earnings data on Wednesday, May 14th after market close, per Finnhub. Analysts are expecting revenue of $14,513,070 and earnings of $0.12 per share.
You can see Quiver Quantitative's $ISSC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INNOVATIVE SOLTNS & SUPP Insider Trading Activity
INNOVATIVE SOLTNS & SUPP insiders have traded $ISSC stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ISSC stock by insiders over the last 6 months:
- CHRISTOPHER HARBORNE has made 0 purchases and 8 sales selling 313,124 shares for an estimated $3,494,807.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INNOVATIVE SOLTNS & SUPP Hedge Fund Activity
We have seen 39 institutional investors add shares of INNOVATIVE SOLTNS & SUPP stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 302,850 shares (+240.7%) to their portfolio in Q4 2024, for an estimated $2,586,338
- UBS GROUP AG added 209,772 shares (+434.3%) to their portfolio in Q4 2024, for an estimated $1,791,452
- MARSHALL WACE, LLP added 150,208 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,282,776
- ROYCE & ASSOCIATES LP removed 78,828 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $673,191
- RENAISSANCE TECHNOLOGIES LLC added 75,100 shares (+18.5%) to their portfolio in Q4 2024, for an estimated $641,353
- CITADEL ADVISORS LLC added 71,427 shares (+inf%) to their portfolio in Q4 2024, for an estimated $609,986
- MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. removed 59,940 shares (-50.0%) from their portfolio in Q1 2025, for an estimated $377,022
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
